Nicotine replacement products

DEFINITION: Nicotine replacement products are used to help people stop smoking. These products work best as part of a program that also includes education, counseling, and psychological support.

How Nicotine Replacement Products Work

Nicotine replacement products provide nicotine without delivering the other harmful carcinogens found in cigarettes and help to wean a person’s body off of nicotine. The typical effects of withdrawal are minimized as one’s body adjusts to not smoking and progressively lower doses of nicotine until the use of the nicotine replacement product is stopped completely.

94415484-89988.jpg

94415484-89989.jpg

Nicotine patches (transdermal nicotine systems) release nicotine through the skin and into the bloodstream. Nicotine gum (nicotine polacrilex) is chewed slowly. It is then stored between the gum and cheek so that the nicotine can be absorbed through the mouth’s lining and into the bloodstream. Nicotine lozenges dissolve slowly in the mouth to release nicotine at a slow, sustained rate. Nicotine nasal spray contains small doses of nicotine that are sprayed into the nasal passages and absorbed into the bloodstream. Nicotine inhalers contain nicotine that is inhaled through the mouth and absorbed in the mouth and throat. Inhalers and nasal spray methods require a prescription in the United States. Some medications are also available by prescription, such as Varenicline (formerly Chantix) and Bupropion (Wellbutrin). Though these products do not contain nicotine, they work in the brain to reduce cravings and other side effects of quitting smoking.

With care, the Centers for Disease Control recommends these products be used in combination, such as using the patch with lozenges. This helps some people succeed and stay smoke-free.

Precautions

Smoking and using nicotine replacement products can be dangerous because nicotine can build up to toxic levels. Since the goal is to quit smoking entirely, one should not smoke while using a nicotine replacement product. Some research indicates that using nicotine replacement therapy (NRT) products one to two weeks before the actual quit day increases the chances of successfully quitting. This is called nicotine preloading, precessation, or pre-quitting NRT. People who combine several quitting strategies often have the most success.

After quitting smoking, the goal is to end the use of nicotine replacement products as well. It may be appropriate for some people to continue using nicotine replacement products longer than the recommended duration. Some people continue to use them for twelve months or longer. Weaning off the medicine is encouraged, but continuing it is preferable to smoking because cigarette smoke contains many harmful chemicals in addition to nicotine.

The presence of other conditions may affect the use of nicotine replacement products. These conditions include, but are not limited to, allergies (nasal spray only); asthma or breathing problems (with inhaler and nasal spray); type 1 diabetes; heart or blood vessel disease; high blood pressure; liver disease; overactive thyroid; stomach ulcer; and recent stroke.

Bibliography

Fiore, Michael C., et al. Treating Tobacco Use and Dependence: 2008 Update. Public Health ServiceClinical Practice Guideline. Washington, DC, US DHHS, 2008.

“Nicotine Replacement Therapy for Quitting Tobacco.” American Cancer Society, 2 Aug. 2021, www.cancer.org/healthy/stay-away-from-tobacco/guide-quitting-smoking/nicotine-replacement-therapy.html. Accessed 19 Sept. 2024.

“Nicotine Replacement Therapy.” MedlinePlus, US National Library of Medicine, NIH, 28 Feb. 2023, medlineplus.gov/ency/article/007438.htm. Accessed 19 Sept. 2024.

Piper, M. E., et al. “A Randomized Placebo-Controlled Clinical Trial of 5 Smoking Cessation Pharmacotherapies.” Archives of General Psychiatry, vol. 66, no. 11, 2009, pp. 1253–1262.

Strandberg-Larsen, K., et al. “Use of Nicotine Replacement Therapy During Pregnancy and Stillbirth: A Cohort Study.” BJOG: International Journal of Obstetrics and Gynaecology, vol. 115, no. 11, 2008, pp. 1405–1410.